In Vitro Cross-Resistance and Collateral Sensitivity in Seven Resistant Small-Cell Lung Cancer Cell Lines: Preclinical Identification of Suitable Drug Partners to Taxotere, Taxol, Topotecan and Gemcitabin

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1997.154
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Characterisation of a Human Small-Cell Lung Cancer Cell Line Resistant to the DNA Topoisomerase I-Directed Drug Topotecan

British Journal of Cancer
Cancer ResearchOncology
1995English

Taxotere: Clinical Trials in Non‐Small Cell Lung Cancer

Oncologist
Cancer ResearchMedicineOncology
1998English

Drug-Adapted Cancer Cell Lines as Preclinical Models of Acquired Resistance

2019English

Establishment and Identification of Small Cell Lung Cancer Cell Lines Having Classic and Variant Features

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1986English

Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-Small Cell Lung Cancer Cell Lines

Journal of Cancer
Oncology
2020English

Association of ATP7A Expression and in Vitro Sensitivity to Cisplatin in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Iressa Increases the Sensitivity of NPC Cell Lines to Taxol

Otolaryngology - Head and Neck Surgery
OtorhinolaryngologySurgery
2010English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy